Physiologically-based pharmacokinetic modeling of pyrene in the rat.

[1]  S. Haddad,et al.  Rate of pyrene metabolism in rat liver post-mitochondrial fractions. , 1997, Toxicology letters.

[2]  K. Krishnan,et al.  A mechanistic algorithm for predicting blood:air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin. , 1996, Toxicology and applied pharmacology.

[3]  J. Levin,et al.  First international workshop on hydroxypyrene as a biomarker for PAH exposure in man--summary and conclusions. , 1995, The Science of the total environment.

[4]  C. Viau,et al.  Background urinary 1-hydroxypyrene levels in non-occupationally exposed individuals in the Province of Québec, Canada, and comparison with its excretion in workers exposed to PAH mixtures. , 1995, The Science of the total environment.

[5]  L. Endrenyi,et al.  Pharmacokinetics of inhaled pyrene in rats. , 1994, Journal of toxicology and environmental health.

[6]  L. Endrenyi,et al.  Percutaneous uptake, distribution, and excretion of pyrene in rats. , 1993, Journal of toxicology and environmental health.

[7]  F. Law,et al.  Distribution of benzo[a]pyrene in pregnant rats following inhalation exposure and a comparison with similar data obtained with pyrene , 1993, Journal of applied toxicology : JAT.

[8]  M E Andersen,et al.  Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[9]  F. Law,et al.  Distribution to the fetus and major organs of the rat following inhalation exposure to pyrene , 1992, Journal of applied toxicology : JAT.

[10]  M E Andersen,et al.  A Physiologically Based Description of Ethylene Oxide Dosimetry in the Rat , 1992, Toxicology and industrial health.

[11]  C. Kennedy,et al.  A biologically based toxicokinetic model for pyrene in rainbow trout. , 1991, Toxicology and applied pharmacology.

[12]  L. Endrenyi,et al.  Pharmacokinetics and bioavailability of pyrene in the rat. , 1991, Journal of toxicology and environmental health.

[13]  P. S. McCroskey,et al.  Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane. , 1990, Toxicology and applied pharmacology.

[14]  P T Henderson,et al.  1-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. , 1988, The Annals of occupational hygiene.

[15]  Y. Sawada,et al.  Physiologically based pharmacokinetics of radioiodinated human beta-endorphin in rats. An application of the capillary membrane-limited model. , 1987, Drug metabolism and disposition: the biological fate of chemicals.

[16]  J. Piskorska-Pliszczynska,et al.  The cytosolic receptor binding affinities and AHH induction potencies of 29 polynuclear aromatic hydrocarbons. , 1986, Toxicology letters.

[17]  P T Henderson,et al.  1-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product , 1985, International archives of occupational and environmental health.

[18]  M E Andersen,et al.  A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. , 1984, Toxicology and applied pharmacology.